The Finnish drug delivery technology company DelSiTech Ltd. announced today that it has initiated new projects with two undisclosed Animal Health companies to develop innovative therapies for veterinary medicine.
“We are very pleased of the increasing interest of Animal Health companies in our silica-based drug delivery technology”, said Lasse Leino, CEO of DelSiTech Ltd.“Controlled release drug products are especially well suited for treatment of animals which are often difficult to treat with conventional dosage forms such as oral tablets. With our technology, we can minimize the problems associated with patient and owner compliance as well as side-effects of potent medications.”